Congressman David Trone, Co-Chair of the 140-Member Bipartisan Mental Health and Substance Use Disorder Task Force, Releases Statement on FDA Approving Narcan for Over-the-Counter Use
March 30, 2023
March 30, 2023
WASHINGTON, March 30 -- Rep. David Trone, D-Maryland, issued the following statement on March 29, 2023:
* * *
Co-Founder and Co-Chair of the Bipartisan Mental Health and Substance Use Disorder Task Force Rep. David Trone (D-MD) released the following statement on the FDA authorizing Narcan for over-the-counter use:
"Studies have shown that more than one in five fatal overdoses could be averted with naloxone if it was distributed to more people in our c . . .
* * *
Co-Founder and Co-Chair of the Bipartisan Mental Health and Substance Use Disorder Task Force Rep. David Trone (D-MD) released the following statement on the FDA authorizing Narcan for over-the-counter use:
"Studies have shown that more than one in five fatal overdoses could be averted with naloxone if it was distributed to more people in our c . . .